Research output per year
Research output per year
- 1 - 50 out of 286 results
Search results
-
2024
Development of an LC-MS/MS Method to Measure Sphingolipids in CSF from Patients with Multiple SclerosisS
Perez-Paramo, Y. X., Dufield, D., Veeramachaneni, R., Parkhurst, E., Harp, C., Ramesh, A., Winger, R. C., Cross, A. H., Gelfand, J. M., Bar-Or, A., Rodney Mathews, W. & Anania, V. G., Mar 1 2024, In: Molecular pharmacology. 105, 3, p. 121-130 10 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Diffusion basis spectrum imaging and diffusion tensor imaging predict persistent black hole formation in multiple sclerosis
Wooliscroft, L., Salter, A., Adusumilli, G., Levasseur, V. A., Sun, P., Lancia, S., Perantie, D. C., Trinkaus, K., Naismith, R. T., Song, S. K. & Cross, A. H., Apr 2024, In: Multiple Sclerosis and Related Disorders. 84, 105494.Research output: Contribution to journal › Article › peer-review
-
Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple Sclerosis
Cross, A. H., Gelfand, J. M., Thebault, S., Bennett, J. L., Von Büdingen, H. C., Cameron, B., Carruthers, R., Edwards, K., Fallis, R., Gerstein, R., Giacomini, P. S., Greenberg, B., Hafler, D. A., Ionete, C., Kaunzner, U. W., Kodama, L., Lock, C., Longbrake, E. E., Musch, B. & Pardo, G. & 13 others, , Apr 8 2024, In: JAMA Neurology. 81, 4, p. 373-383 11 p.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
Exploring the association between weight loss-inducing medications and multiple sclerosis: insights from the FDA adverse event reporting system database
Shirani, A., Cross, A. H. & Stuve, O., Jan 1 2024, In: Therapeutic Advances in Neurological Disorders. 17Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Functional outcomes of diets in multiple sclerosis (FOOD for MS): Protocol for a parallel arm randomized feeding trial for low glycemic load and calorie restriction
Martin, K., Cofield, S. S., Cross, A. H., Goss, A. M., Raji, C. A., Rinker, J. R., Wu, G. F., Blair, J., Fuchs, A., Ghezzi, L., Green, K., Pace, F., Pastori, G., Taylor, M. G., Piccio, L. & Wingo, B. C., Aug 2024, In: Contemporary Clinical Trials. 143, 107584.Research output: Contribution to journal › Article › peer-review
-
Prevalence of anti-myelin oligodendrocyte glycoprotein antibodies across neuroinflammatory and neurodegenerative diseases
Trivedi, R. R., Archambault, A. S., Pavlak, C., Gastaldi, M., Cantoni, C., Ghezzi, L., Cross, A. H., Miller, T. M. & Wu, G. F., Jun 15 2024, In: Journal of the Neurological Sciences. 461, 123041.Research output: Contribution to journal › Article › peer-review
-
Role of B Cells in Relapsing-Remitting and Progressive Multiple Sclerosis and Long-Term Effects of B Cell Depletion
Shirani, A., Stuve, O. & Cross, A. H., Feb 2024, In: Neurologic Clinics. 42, 1, p. 137-153 17 p.Research output: Contribution to journal › Review article › peer-review
-
Unexpected Low Rate of Amyloid-β Pathology in Multiple Sclerosis Patients
Brier, M. R., Schindler, S. E., Salter, A., Perantie, D., Shelley, N., Judge, B., Keefe, S., Kirmess, K. M., Verghese, P. B., Yarasheski, K. E., Venkatesh, V., Raji, C. A., Gordon, B. A., Bateman, R. J., Morris, J. C., Naismith, R. T., Holtzman, D. M., Benzinger, T. L. S. & Cross, A. H., Sep 2024, In: Annals of neurology. 96, 3, p. 453-459 7 p.Research output: Contribution to journal › Article › peer-review
-
2023
Antibody response to SARS-CoV-2 vaccines in patients with relapsing multiple sclerosis treated with evobrutinib: A Bruton’s tyrosine kinase inhibitor
Bar-Or, A., Cross, A. H., Cunningham, A. L., Hyvert, Y., Seitzinger, A., Gühring, H., Drouin, E. E., Alexandri, N., Tomic, D. & Montalban, X., Oct 2023, In: Multiple Sclerosis Journal. 29, 11-12, p. 1471-1481 11 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase 3 clinical trials
Bar-Or, A., Thanei, G. A., Harp, C., Bernasconi, C., Bonati, U., Cross, A. H., Fischer, S., Gaetano, L., Hauser, S. L., Hendricks, R., Kappos, L., Kuhle, J., Leppert, D., Model, F., Sauter, A., Koendgen, H., Jia, X. & Herman, A. E., Jul 2023, In: EBioMedicine. 93, 104662.Research output: Contribution to journal › Article › peer-review
Open Access20 Scopus citations -
Demographics and baseline disease characteristics of Black and Hispanic patients with multiple sclerosis in the open-label, single-arm, multicenter, phase IV CHIMES trial
CHIMES investigators, Aug 2023, In: Multiple Sclerosis and Related Disorders. 76, 104794.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Design and Baseline Characteristics of Phase 3, Double-Blind, Randomised Trials Evaluating the Efficacy and Safety of Evobrutinib Versus Teriflunomide in Relapsing Multiple Sclerosis (evolutionRMS 1 and 2)
Montalban, X., Vermersch, P., Arnold, D. L., Bar-Or, A., Cree, B. A. C., Cross, A., Havrdova, E. K., Kappos, L., Stuve, O., Wiendl, H., Wolinsky, J., Bolay, C. L., Hyvert, Y., Javor, A., Guehring, H., Tenenbaum, N. & Tomic, D., Dec 2023, In: Multiple Sclerosis and Related Disorders. 80, 105328.Research output: Contribution to journal › Conference article › peer-review
1 Scopus citations -
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity
Shinoda, K., Li, R., Rezk, A., Mexhitaj, I., Patterson, K. R., Kakara, M., Zuroff, L., Bennett, J. L., von Büdingen, H. C., Carruthers, R., Edwards, K. R., Fallis, R., Giacomini, P. S., Greenberg, B. M., Hafler, D. A., Ionete, C., Kaunzner, U. W., Lock, C. B., Longbrake, E. E. & Pardo, G. & 13 others, , Jan 17 2023, In: Proceedings of the National Academy of Sciences of the United States of America. 120, 3, e2207291120.Research output: Contribution to journal › Article › peer-review
Open Access21 Scopus citations -
Humoral immune response to COVID-19 mRNA vaccines in patients with relapsing multiple sclerosis treated with ofatumumab
Bar-Or, A., Aburashed, R., Chinea, A. R., Hendin, B. A., Lucassen, E., Meng, X., Stankiewicz, J., Tullman, M. J. & Cross, A. H., Nov 2023, In: Multiple Sclerosis and Related Disorders. 79, 104967.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Is Autologous Hematopoietic Stem Cell Transplant Better Than High-Efficacy Disease-Modifying Therapies for Relapsing Multiple Sclerosis?
Cohen, J. A. & Cross, A. H., Jul 10 2023, In: JAMA Neurology. 80, 7, p. 669-672 4 p.Research output: Contribution to journal › Editorial
1 Scopus citations -
Obesity, gut microbiota, and multiple sclerosis: Unraveling the connection
Samara, A., Cantoni, C., Piccio, L., Cross, A. H. & Chahin, S., Aug 2023, In: Multiple Sclerosis and Related Disorders. 76, 104768.Research output: Contribution to journal › Review article › peer-review
4 Scopus citations -
Quantitative Analysis of S1PR1 Expression in the Postmortem Multiple Sclerosis Central Nervous System
Jiang, H., Zhou, C., Qiu, L., Gropler, R. J., Brier, M. R., Wu, G. F., Cross, A. H., Perlmutter, J. S., Benzinger, T. L. S. & Tu, Z., Nov 15 2023, In: ACS Chemical Neuroscience. 14, 22, p. 4039-4050 12 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Quantitative MRI identifies lesional and non-lesional abnormalities in MOGAD
Brier, M. R., Xiang, B., Ciotti, J. R., Chahin, S., Wu, G. F., Naismith, R. T., Yablonskiy, D. & Cross, A. H., May 2023, In: Multiple Sclerosis and Related Disorders. 73, 104659.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Risk of new disease activity in patients with multiple sclerosis who continue or discontinue disease-modifying therapies (DISCOMS): a multicentre, randomised, single-blind, phase 4, non-inferiority trial
DISCOMS investigators, Jul 2023, In: The Lancet Neurology. 22, 7, p. 568-577 10 p.Research output: Contribution to journal › Article › peer-review
39 Scopus citations -
Schwann Cell Remyelination in the Multiple Sclerosis Central Nervous System
Ghezzi, L., Bollman, B., De Feo, L., Piccio, L., Trapp, B. D., Schmidt, R. E. & Cross, A. H., Jun 2023, In: Laboratory Investigation. 103, 6, 100128.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Targeting miR-223 enhances myeloid-derived suppressor cell suppressive activities in multiple sclerosis patients
Cantoni, C., Ghezzi, L., Choi, J., Cross, A. H. & Piccio, L., Aug 2023, In: Multiple Sclerosis and Related Disorders. 76, 104839.Research output: Contribution to journal › Article › peer-review
5 Scopus citations -
“Brain age” predicts disability accumulation in multiple sclerosis
Brier, M. R., Li, Z., Ly, M., Karim, H. T., Liang, L., Du, W., McCarthy, J. E., Cross, A. H., Benzinger, T. L. S., Naismith, R. T. & Chahin, S., Jun 2023, In: Annals of Clinical and Translational Neurology. 10, 6, p. 990-1001 12 p.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
2022
Alterations of host-gut microbiome interactions in multiple sclerosis
Cantoni, C., Lin, Q., Dorsett, Y., Ghezzi, L., Liu, Z., Pan, Y., Chen, K., Han, Y., Li, Z., Xiao, H., Gormley, M., Liu, Y., Bokoliya, S., Panier, H., Suther, C., Evans, E., Deng, L., Locca, A., Mikesell, R. & Obert, K. & 8 others, , Feb 2022, In: EBioMedicine. 76, 103798.Research output: Contribution to journal › Article › peer-review
Open Access69 Scopus citations -
Central vein sign and other radiographic features distinguishing myelin oligodendrocyte glycoprotein antibody disease from multiple sclerosis and aquaporin-4 antibody-positive neuromyelitis optica
Ciotti, J. R., Eby, N. S., Brier, M. R., Wu, G. F., Chahin, S., Cross, A. H. & Naismith, R., Jan 2022, In: Multiple Sclerosis Journal. 28, 1, p. 49-60 12 p.Research output: Contribution to journal › Article › peer-review
17 Scopus citations -
Charting a global research strategy for progressive MS—An international progressive MS Alliance proposal
Thompson, A. J., Carroll, W., Ciccarelli, O., Comi, G., Cross, A., Donnelly, A., Feinstein, A., Fox, R. J., Helme, A., Hohlfeld, R., Hyde, R., Kanellis, P., Landsman, D., Lubetzki, C., Marrie, R. A., Morahan, J., Montalban, X., Musch, B., Rawlings, S. & Salvetti, M. & 6 others, , Jan 2022, In: Multiple Sclerosis Journal. 28, 1, p. 16-28 13 p.Research output: Contribution to journal › Review article › peer-review
Open Access9 Scopus citations -
Confirming a Historical Diagnosis of Multiple Sclerosis: Challenges and Recommendations
Solomon, A. J., Arrambide, G., Brownlee, W., Cross, A. H., Gaitan, M. I., Lublin, F. D., Makhani, N., Mowry, E. M., Reich, D. S., Rovira, À., Weinshenker, B. G. & Cohen, J. A., Jun 1 2022, In: Neurology: Clinical Practice. 12, 3, p. 263-269 7 p.Research output: Contribution to journal › Review article › peer-review
Open Access5 Scopus citations -
Correction to: COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab (Neurology and Therapy, (2022), 11, 2, (741-758), 10.1007/s40120-022-00341-z)
Cross, A. H., Delgado, S., Habek, M., Davydovskaya, M., Ward, B. J., Cree, B. A. C., Totolyan, N., Pingili, R., Mancione, L., Hu, X., Sullivan, R., Su, W., Zielman, R., Gupta, A. D., Montalban, X. & Winthrop, K., Jun 2022, In: Neurology and Therapy. 11, 2, p. 759-762 4 p.Research output: Contribution to journal › Comment/debate
Open Access1 Scopus citations -
COVID-19 in the pregnant or postpartum MS patient: Symptoms and outcomes
Salter, A., Cross, A. H., Cutter, G. R., Fox, R. J., Li, D. K. B., Bebo, B., Halper, J., Kanellis, P., Rammohan, K. & Newsome, S. D., Sep 2022, In: Multiple Sclerosis and Related Disorders. 65, 104028.Research output: Contribution to journal › Letter › peer-review
Open Access4 Scopus citations -
COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab
Cross, A. H., Delgado, S., Habek, M., Davydovskaya, M., Ward, B. J., Cree, B. A. C., Totolyan, N., Pingili, R., Mancione, L., Hu, X., Sullivan, R., Su, W., Zielman, R., Gupta, A. D., Montalban, X. & Winthrop, K., Jun 2022, In: Neurology and Therapy. 11, 2, p. 741-758 18 p.Research output: Contribution to journal › Article › peer-review
Open Access21 Scopus citations -
Efficacy and safety of ofatumumab in recently diagnosed, treatment-naive patients with multiple sclerosis: Results from ASCLEPIOS I and II
Gärtner, J., Hauser, S. L., Bar-Or, A., Montalban, X., Cohen, J. A., Cross, A. H., Deiva, K., Ganjgahi, H., Häring, D. A., Li, B., Pingili, R., Ramanathan, K., Su, W., Willi, R., Kieseier, B. & Kappos, L., Sep 2022, In: Multiple Sclerosis Journal. 28, 10, p. 1562-1575 14 p.Research output: Contribution to journal › Article › peer-review
Open Access40 Scopus citations -
Evaluating brain damage in multiple sclerosis with simultaneous multi-angular-relaxometry of tissue
Xiang, B., Wen, J., Schmidt, R. E., Sukstanskii, A. L., Mamah, D., Yablonskiy, D. A. & Cross, A. H., Oct 2022, In: Annals of Clinical and Translational Neurology. 9, 10, p. 1514-1527 14 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Further support for rituximab in relapsing multiple sclerosis
Naismith, R. T. & Cross, A., Aug 2022, In: The Lancet Neurology. 21, 8, p. 672-673 2 p.Research output: Contribution to journal › Comment/debate
1 Scopus citations -
MINI-review of Epstein-Barr virus involvement in multiple sclerosis etiology and pathogenesis
Aloisi, F. & Cross, A. H., Oct 15 2022, In: Journal of Neuroimmunology. 371, 577935.Research output: Contribution to journal › Review article › peer-review
6 Scopus citations -
Prognostic Value of Serum Neurofilament Light Chain for Disease Activity and Worsening in Patients With Relapsing Multiple Sclerosis: Results From the Phase 3 ASCLEPIOS I and II Trials
Ziemssen, T., Arnold, D. L., Alvarez, E., Cross, A. H., Willi, R., Li, B., Kukkaro, P., Kropshofer, H., Ramanathan, K., Merschhemke, M., Kieseier, B., Su, W., Häring, D. A., Hauser, S. L., Kappos, L. & Kuhle, J., Mar 31 2022, In: Frontiers in immunology. 13, 852563.Research output: Contribution to journal › Article › peer-review
Open Access22 Scopus citations -
Safety experience with continued exposure to ofatumumab in patients with relapsing forms of multiple sclerosis for up to 3.5 years
Hauser, S. L., Cross, A. H., Winthrop, K., Wiendl, H., Nicholas, J., Meuth, S. G., Giacomini, P. S., Saccà, F., Mancione, L., Zielman, R., Bagger, M., Das Gupta, A., Häring, D. A., Jehl, V., Kieseier, B. C., Pingili, R., Stoneman, D., Su, W., Willi, R. & Kappos, L., Sep 2022, In: Multiple Sclerosis Journal. 28, 10, p. 1576-1590 15 p.Research output: Contribution to journal › Article › peer-review
Open Access34 Scopus citations -
Stronger Microstructural Damage Revealed in Multiple Sclerosis Lesions With Central Vein Sign by Quantitative Gradient Echo MRI
Levasseur, V. A., Xiang, B., Salter, A., Yablonskiy, D. A. & Cross, A. H., Mar 28 2022, In: Journal of Central Nervous System Disease. 14Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
The CELLO trial: Protocol of a planned phase 4 study to assess the efficacy of Ocrelizumab in patients with radiologically isolated syndrome
Longbrake, E. E., Hua, L. H., Mowry, E. M., Gauthier, S. A., Alvarez, E., Cross, A. H., Pei, J., Priest, J., Raposo, C., Hafler, D. A. & Winger, R. C., Dec 2022, In: Multiple Sclerosis and Related Disorders. 68, 104143.Research output: Contribution to journal › Article › peer-review
Open Access9 Scopus citations -
Tissue damage detected by quantitative gradient echo MRI correlates with clinical progression in non-relapsing progressive MS
Xiang, B., Brier, M. R., Kanthamneni, M., Wen, J., Snyder, A. Z., Yablonskiy, D. A. & Cross, A. H., Sep 2022, In: Multiple Sclerosis Journal. 28, 10, p. 1515-1525 11 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Treatment of Multiple Sclerosis
Goldman, M. D., Cross, A. & Riley, C., Aug 1 2022, In: CONTINUUM Lifelong Learning in Neurology. 28, 4, p. 1025-1051 27 p.Research output: Contribution to journal › Article › peer-review
19 Scopus citations -
2021
Alterations of the gut mycobiome in patients with MS
Shah, S., Locca, A., Dorsett, Y., Cantoni, C., Ghezzi, L., Lin, Q., Bokoliya, S., Panier, H., Suther, C., Gormley, M., Liu, Y., Evans, E., Mikesell, R., Obert, K., Salter, A., Cross, A. H., Tarr, P. I., Lovett-Racke, A., Piccio, L. & Zhou, Y., Sep 2021, In: EBioMedicine. 71, 103557.Research output: Contribution to journal › Article › peer-review
Open Access44 Scopus citations -
Anti-CD20 B Cell Treatment for Relapsing Multiple Sclerosis
Roach, C. A. & Cross, A. H., Jan 22 2021, In: Frontiers in Neurology. 11, 595547.Research output: Contribution to journal › Review article › peer-review
Open Access28 Scopus citations -
CD11c+CD88+CD317+ myeloid cells are critical mediators of persistent CNS autoimmunity
Manouchehri, N., Hussain, R. Z., Cravens, P. D., Esaulova, E., Artyomov, M. N., Edelson, B. T., Wu, G. F., Cross, A. H., Doelger, R., Loof, N., Eagar, T. N., Forsthuber, T. G., Calvier, L., Herz, J. & Stüve, O., Apr 6 2021, In: Proceedings of the National Academy of Sciences of the United States of America. 118, 14, e2014492118.Research output: Contribution to journal › Article › peer-review
Open Access13 Scopus citations -
COVID-19 in Patients With Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody Disease in North America: From the COViMS Registry
Newsome, S. D., Cross, A. H., Fox, R. J., Halper, J., Kanellis, P., Bebo, B., Li, D., Cutter, G. R., Rammohan, K. W. & Salter, A., Sep 24 2021, In: Neurology: Neuroimmunology and NeuroInflammation. 8, 5, e1057.Research output: Contribution to journal › Article › peer-review
Open Access18 Scopus citations -
Diffusion Basis Spectrum Imaging Detects Axonal Loss After Transient Dexamethasone Treatment in Optic Neuritis Mice
Lin, T. H., Zhan, J., Song, C., Wallendorf, M., Sun, P., Niu, X., Yang, R., Cross, A. H. & Song, S. K., Jan 22 2021, In: Frontiers in Neuroscience. 14, 592063.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Diffusion basis spectrum imaging measures anti-inflammatory and neuroprotective effects of fingolimod on murine optic neuritis
Yang, R., Lin, T. H., Zhan, J., Lai, S., Song, C., Sun, P., Ye, Z., Wallendorf, M., George, A., Cross, A. H. & Song, S. K., Jan 2021, In: NeuroImage: Clinical. 31, 102732.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Effects of dietary restriction on neuroinflammation in neurodegenerative diseases
Fontana, L., Ghezzi, L., Cross, A. H. & Piccio, L., 2021, In: Journal of Experimental Medicine. 218, 2, e20190086.Research output: Contribution to journal › Review article › peer-review
Open Access59 Scopus citations -
Immunology of multiple sclerosis
Wu, G. F. & Cross, A. H., Apr 9 2021, Neuroimmunology: Multiple Sclerosis, Autoimmune Neurology and Related Diseases. Springer International Publishing, p. 117-135 19 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review
2 Scopus citations -
In Vitro and in Vivo Investigation of S1PR1 Expression in the Central Nervous System Using [3H]CS1P1 and [11C]CS1P1
Jiang, H., Joshi, S., Liu, H., Mansor, S., Qiu, L., Zhao, H., Whitehead, T., Gropler, R. J., Wu, G. F., Cross, A. H., Benzinger, T. L. S., Shoghi, K. I., Perlmutter, J. S. & Tu, Z., Oct 6 2021, In: ACS Chemical Neuroscience. 12, 19, p. 3733-3744 12 p.Research output: Contribution to journal › Article › peer-review
Open Access14 Scopus citations -
MS can be considered a primary progressive disease in all cases, but some patients have superimposed relapses – No
Cross, A. H. & Naismith, R. T., Jun 2021, In: Multiple Sclerosis Journal. 27, 7, p. 1004-1005 2 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Outcomes and Risk Factors Associated with SARS-CoV-2 Infection in a North American Registry of Patients with Multiple Sclerosis
Salter, A., Fox, R. J., Newsome, S. D., Halper, J., Li, D. K. B., Kanellis, P., Costello, K., Bebo, B., Rammohan, K., Cutter, G. R. & Cross, A. H., Jun 2021, In: JAMA Neurology. 78, 6, p. 699-708 10 p.Research output: Contribution to journal › Article › peer-review
Open Access215 Scopus citations